192 related articles for article (PubMed ID: 14754977)
41. Fluticasone propionate in asthma: a long term dose comparison study.
Verona E; Petrov D; Cserhati E; Hofman J; Geppe N; Medley H; Hughes S
Arch Dis Child; 2003 Jun; 88(6):503-9. PubMed ID: 12765916
[TBL] [Abstract][Full Text] [Related]
42. Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age.
Creticos P; Knobil K; Edwards LD; Rickard KA; Dorinsky P
Ann Allergy Asthma Immunol; 2002 Apr; 88(4):401-9. PubMed ID: 11991558
[TBL] [Abstract][Full Text] [Related]
43. Short-Term Growth During Treatment with Inhaled Fluticasone Propionate/Formoterol, Fluticasone and Beclomethasone Treatment.
Wolthers OD; Moore A; Mersmann S; Dissanayake S
J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):373-380. PubMed ID: 28510491
[TBL] [Abstract][Full Text] [Related]
44. Effects of nebulized corticosteroids therapy on hypothalamic-pituitary-adrenal axis in young children with recurrent or persistent wheeze.
Cetinkaya F; Kayiran P; Memioglu N; Tarim OF; Eren N; Erdem E
Pediatr Allergy Immunol; 2008 Dec; 19(8):773-6. PubMed ID: 18221460
[TBL] [Abstract][Full Text] [Related]
45. Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma.
Vaessen-Verberne AA; van den Berg NJ; van Nierop JC; Brackel HJ; Gerrits GP; Hop WC; Duiverman EJ;
Am J Respir Crit Care Med; 2010 Nov; 182(10):1221-7. PubMed ID: 20622031
[TBL] [Abstract][Full Text] [Related]
46. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
Clark DJ; Lipworth BJ
Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246
[TBL] [Abstract][Full Text] [Related]
47. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.
Clark DJ; Grove A; Cargill RI; Lipworth BJ
Thorax; 1996 Mar; 51(3):262-6. PubMed ID: 8779128
[TBL] [Abstract][Full Text] [Related]
48. Fluticasone propionate in children with moderate asthma.
Hoekstra MO; Grol MH; Bouman K; Stijnen T; Köeter GH; Kauffman HF; Gerritsen J
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1039-44. PubMed ID: 8887604
[TBL] [Abstract][Full Text] [Related]
49. The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast.
Lanz MJ; Eisenlohr C; Llabre MM; Toledo Y; Lanz MA
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):283-8. PubMed ID: 11686419
[TBL] [Abstract][Full Text] [Related]
50. Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group.
Allen DB; Bronsky EA; LaForce CF; Nathan RA; Tinkelman DG; Vandewalker ML; Konig P
J Pediatr; 1998 Mar; 132(3 Pt 1):472-7. PubMed ID: 9544904
[TBL] [Abstract][Full Text] [Related]
51. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
[TBL] [Abstract][Full Text] [Related]
52. Salmeterol/fluticasone propionate combination.
Spencer CM; Jarvis B
Drugs; 1999 Jun; 57(6):933-40; discussion 941-3. PubMed ID: 10400406
[TBL] [Abstract][Full Text] [Related]
53. The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma.
Malone R; LaForce C; Nimmagadda S; Schoaf L; House K; Ellsworth A; Dorinsky P
Ann Allergy Asthma Immunol; 2005 Jul; 95(1):66-71. PubMed ID: 16095144
[TBL] [Abstract][Full Text] [Related]
54. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma.
ZuWallack R; Adelglass J; Clifford DP; Duke SP; Wire PD; Faris M; Harding SM
Chest; 2000 Aug; 118(2):303-12. PubMed ID: 10936117
[TBL] [Abstract][Full Text] [Related]
55. Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group.
Tonnel AB; Bons J; Legendre M; Prud'Homme A; Bugnas B; Evano-Celli I; Stuart AM
Respir Med; 2000 Jun; 94 Suppl B():S29-34. PubMed ID: 10919683
[TBL] [Abstract][Full Text] [Related]
56. Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroids.
Lumry WR; Conway MM; LaForce CF; Pearlman DS; Scott CA; Herje NE; Wu WW; Crim C
Ann Allergy Asthma Immunol; 2006 Jan; 96(1):51-9. PubMed ID: 16440533
[TBL] [Abstract][Full Text] [Related]
57. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma.
Pearlman DS; Noonan MJ; Tashkin DP; Goldstein MF; Hamedani AG; Kellerman DJ; Schaberg A
Ann Allergy Asthma Immunol; 1997 Apr; 78(4):356-62. PubMed ID: 9109702
[TBL] [Abstract][Full Text] [Related]
58. Efficacy and tolerability of salmeterol/fluticasone propionate versus fluticasone propionate in asthma patients: a randomized, double-blind study.
Lee YS; Lin HC; Huang CD; Lee KY; Liu CY; Yu CT; Wang CH; Kuo HP
Chang Gung Med J; 2011; 34(4):382-94. PubMed ID: 21880193
[TBL] [Abstract][Full Text] [Related]
59. Comparison of once- with twice-daily dosing of fluticasone propionate in mild and moderate asthma.
Boulet LP; Cowie RL; Negro RD; Brett W; Gold M; Marques A; Thorburn WS; Stepner NM; Robson R
Can Respir J; 2000; 7(3):239-47. PubMed ID: 10903487
[TBL] [Abstract][Full Text] [Related]
60. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
Gustafsson P; Tsanakas J; Gold M; Primhak R; Radford M; Gillies E
Arch Dis Child; 1993 Aug; 69(2):206-11. PubMed ID: 8215522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
